Objective: Ketamine has emerged as a rapid-acting antidepressant, though controversy
remains whether sufficient data exist to justify its use outside of research protocols. In …

Method: Initially, patients were treated with a single-or double-infusion protocol (0.5 mg/kg
over 40 minutes intravenously). We later transitioned to a 4-infusion protocol over two …

Objective: Ketamine has emerged as a rapid-acting antidepressant, though controversy
remains whether sufficient data exist to justify its use outside of research protocols. In …

Objective Ketamine has emerged as a rapid-acting antidepressant, though controversy
remains whether sufficient data exist to justify its use outside of research protocols. In …

Introduction: Ketamine has emerged as a rapid-acting antidepressant, though controversy
remains regarding whether sufficient data exist to justify its use outside of research …

Objective: Ketamine has emerged as a rapid-acting antidepressant, though controversy
remains whether sufficient data exist to justify its use outside of research protocols. In …

Objective Ketamine has emerged as a rapid-acting antidepressant, though controversy
remains whether sufficient data exist to justify its use outside of research protocols. In …

Introduction: Ketamine has emerged as a rapid-acting antidepressant, though controversy
remains regarding whether sufficient data exist to justify its use outside of research …

Objective: Ketamine has emerged as a rapid-acting antidepressant, though controversy
remains whether sufficient data exist to justify its use outside of research protocols. In …